Tag | Content |
---|
EnhancerAtlas ID | HS162-04297 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr17:46582570-46583800 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL2 | MA0478.1 | chr17:46583373-46583384 | GGATGACTCAT | + | 6.62 | Foxa2 | MA0047.2 | chr17:46583182-46583194 | ACTATGTAAACA | - | 6.22 | JUN(var.2) | MA0489.1 | chr17:46583370-46583384 | AATGGATGACTCAT | + | 6.13 | JUNB | MA0490.1 | chr17:46583373-46583384 | GGATGACTCAT | + | 6.62 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_51776 | chr17:46583267-46584540 | Skeletal_Muscle_Myoblast | SE_63564 | chr17:46583156-46584583 | HSMM |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr17 | 46583140 | 46583597 | chr17 | 46582981 | 46583021 | chr17 | 46583139 | 46583523 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I048505 | chr17 | 46582513 | 46584297 |
|
Enhancer Sequence | GATACTAGTA CCTAAGTCAC AGGCTGGTTG TGAGGGTTAA ACACTAAGAC ATGTGAAGAA 60 AGCACTTATC AGAGCACCTG ATACACTAAA CTCTCAGTTA ATGGCCATCA TTGTCAGTAA 120 TGAGACTCAA CCATTAAAAT AAAACTTGGA GACAGGATTT ATGGAAGAAA GTTTCAAAGG 180 GGCAGATTTC AGCACAGAAA ACAGATTTAT TCTTTTTTGA AAAAAGTTTA TTACAGAAAA 240 ATTCAAACAT ATACATAAAT AAAAGAATAT AATGAACTTC CATATACCCA ACAACACCCA 300 GCTTCAACAA TTATCAATCA AGGCCACTTT TATATCATGC AAACTGCTCT AGATGGATCT 360 AGTCCATTTT AATCTAGTTA TTTTGGTCAC AAGGGTAGGT ATTTTCTTAT AGGAGAGGGA 420 ATTCGGGATT TAGAGTCTGA AAATGTGTTT CACCTTTGAT TAAATGTATG ACCTTGGGCA 480 GGTCACTTAA TTCTTTTGAT CCTCAGTAAA ATGAAGATCT TTCATCTGTA AAATAAAATT 540 GATAACACTG GCTACACATA CAAAAAGTGT ACAGGCAGTG AGATGTCTGT GAAAGAGGCT 600 CAAAAAGGAA GCACTATGTA AACACCTGCC ACTGTGTACA GCACCAGGTG TGGCTCAACA 660 AACATTTATT GAGGTTATTG TTAAGTATTA GGTCATGCCA AAAAAAAAAG AGAAAACCCA 720 ACTCTTCAAT TTTAGGTTGC ACCATTGAGC TTCTCTTGTC ACATTGCAAA TGTGGTCACT 780 AAGGCAACTG GGCCAGACAG AATGGATGAC TCATCCTGCT CCAACCTAGT ATGCACATCC 840 TGTTGGTCCA GGAGAGTCAC TTCTCATACC ACATGTCCTT GTTCAATGTC AAGGCCTGGA 900 AAATGTCAAA TCATGTCAAA AGTCTCCAGT CCTATATCTC CGTGAAGGTT CAGAGTGAGA 960 ACTGCAGAGC CAGTGGGCAA GACCTGAAAA TTATATTTTG AAAAAGCAGC TGTTGTGAAC 1020 ACAAGCCAAA TCACCCTTTC AAAAAGAATT TGGAGGTAAG TCTCAGATAC AGAATTTAAA 1080 GCTGCAAGAG GAGACTATAG GTGAATGCCT GACCCAAAGG TTGGTCCGAA AACTATTTTG 1140 ACTACAGCCA GAGAGATGCT ATTTCTTCCT TATTTTTCTT CCCTTACAGA GAAGAGAATT 1200 TTAGAATTTC ATCTTTGCCC TAACCTCTGC 1230
|